Patient-Reported Outcomes In Patients With Primary Advanced Or Recurrent Endometrial Cancer Treated With Chemotherapy Plus Dostarlimab Or Placebo In The ENGOT-EN6-NSGO/GOG3031/RUBY Trial Over 3 Years Of Follow-Up

---

Sharma S., Lindahl G., Landrum L. M., Pishchyk M., Gilbert L., Gill S., ...More

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, no.2, 2025 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Publication Date: 2025
• Doi Number: 10.1016/j.ijgc.2024.100243
• Journal Name: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, CAB Abstracts, EMBASE, MEDLINE
• Hacettepe University Affiliated: Yes